
Epinoma
Epinoma is a YC Summer 2021 (S21) company. Based in San Francisco, CA, USA. Team of 8.
About Epinoma
Summary
Epinoma develops epigenetic tools and therapies, starting with EpiAmp, a methyl-preserving DNA amplification technology that replaces current conversion-based methods prone to noise and sequence degradation. Its work targets three areas: early detection of diseases such as cancer and neurodegeneration through methylation analysis, programmable epigenetic medicines that alter gene expression without changing the underlying DNA sequence, and biopharma drug development through comparison of healthy and diseased epigenetic states.
Go-to-market
Biopharma and research organizations are the primary customers, reached through partnerships for both tool licensing and therapeutic co-development.
From the Y Combinator listing
We engineer proteins that control the operating system of biology.
Facts
- Healthcare / Healthcare
- San Francisco, CA, USA
- 8
- Active
- Early
Founders (2)
- Varun Govil
- Zhijian Li
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works